These two have been beat down badly for a while. As a matter of fact, the pharma sector is down heavily. I am interested in getting my feet in this sector. I am contemplating which of these two have a better growth and outlook in the future. It seems PFE pays better dividends but BMY has less debts. Based on my research they are managing their debts much better than PFE but who knows. Do they have any miracle drugs coming in the pipeline? It seems PFE is going for weight loss drugs that are about to get some noise and etc. what’s your thought on these two companies. Both have terrible 2 and 5 years returns. Do you believe it’s worth taking a look at these two? Let’s hear it.
Leave a Reply